文献速递腹部技术与安全PETCT

FDG PET/CT在消化道恶性肿瘤中的临床影响:最新综述

Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

本综述结合文献与相关图像,聚焦PET/CT在食管癌、胃癌和结直肠癌诊断(含病理/临床分期)及治疗后随访中的当前作用。PET/CT有助于食管癌远处病变检出、胃癌实体器官转移识别与新辅助化疗后应答者与非应答者区分,以及结直肠癌肝转移和其他远处转移检出、治疗反应评估和鉴别放疗后改变与肿瘤复发。综述还强调了消化道病变PET/CT判读中的若干陷阱。

要点

  • PET/CT可检出食管癌切除前的远处病变。
  • 胃癌中PET/CT有助于检出实体器官转移并区分新辅助化疗后应答者与非应答者。
  • GIST中PET/CT判断伊马替尼治疗反应较增强CT更快捷。

关键影像表现/征象

  • 食管癌:PET/CT可用于检出切除前远处病变。
  • 胃癌:PET/CT有助于检出实体器官转移,并可区分新辅助化疗后应答者与非应答者,非应答者总生存更差。
  • GIST:PET/CT判断伊马替尼治疗反应较增强CT更快捷。
  • 结直肠癌:PET/CT有助于检出肝转移和其他远处转移、评估治疗反应,并鉴别放疗后改变与肿瘤复发。

临床应用与阅片要点

  • 食管癌切除前可用PET/CT检出远处病变。
  • 胃癌新辅助化疗后可用PET/CT区分应答者与非应答者,非应答者总生存更差。
  • GIST伊马替尼治疗中PET/CT判断反应较增强CT更快捷。
  • 结直肠癌可用PET/CT检出肝转移和其他远处转移、评估治疗反应,并鉴别放疗后改变与肿瘤复发。
  • 判读消化道病变时需注意PET/CT的若干陷阱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The use of 18F-fluorodeoxyglucose (FDG) positron emission tomography combined with computed tomography (PET/CT) is well established in the evaluation of alimentary tract malignancies. This review of the literature and demonstration of correlative images focuses on the current role of PET/CT in the diagnosis (including pathologic/clinical staging) and post-therapy follow-up of esophageal, gastric, and colorectal cancers. PET/CT provides utility in the management of esophageal cancer, including detection of distant disease prior to resection. In gastric cancer, PET/CT is useful in detecting solid organ metastases and in characterizing responders vs. non-responders after neoadjuvant chemotherapy, the latter of which have poorer overall survival. In patients with GIST tumors, PET/CT also determines response to imatinib therapy with greater expedience as compared to CECT. For colorectal cancer, PET/CT has proven helpful in detecting hepatic and other distant metastases, treatment response, and differentiating post-radiation changes from tumor recurrence. Our review also highlights several pitfalls in PET/CT interpretation of alimentary tract lesions.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Akin EA, Qazi ZN, Osman M, et al. Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review. Abdom Radiol (NY). 2020. PMID: 32152644. doi:10.1007/s00261-020-02447-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。